Last reviewed · How we verify
Dapsone Topical Gel + adapalene gel 0.1%
Dapsone Topical Gel + adapalene gel 0.1% is a Combination topical antimicrobial and retinoid Small molecule drug developed by Allergan. It is currently in Phase 3 development for Acne vulgaris.
Dapsone provides antimicrobial and anti-inflammatory effects while adapalene is a retinoid that normalizes skin cell differentiation and reduces inflammation.
Dapsone provides antimicrobial and anti-inflammatory effects while adapalene is a retinoid that normalizes skin cell differentiation and reduces inflammation. Used for Acne vulgaris.
At a glance
| Generic name | Dapsone Topical Gel + adapalene gel 0.1% |
|---|---|
| Sponsor | Allergan |
| Drug class | Combination topical antimicrobial and retinoid |
| Target | Retinoic acid receptor (adapalene); dihydropteroate synthase inhibition (dapsone) |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
Dapsone acts as a sulfone antimicrobial agent with immunomodulatory properties, suppressing neutrophil function and reducing inflammatory mediators. Adapalene is a third-generation retinoid that binds to retinoic acid receptors, promoting cell turnover and reducing comedone formation. Together, the combination targets both bacterial and inflammatory components of acne.
Approved indications
- Acne vulgaris
Common side effects
- Erythema
- Dryness
- Peeling
- Irritation
- Photosensitivity
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dapsone Topical Gel + adapalene gel 0.1% CI brief — competitive landscape report
- Dapsone Topical Gel + adapalene gel 0.1% updates RSS · CI watch RSS
- Allergan portfolio CI
Frequently asked questions about Dapsone Topical Gel + adapalene gel 0.1%
What is Dapsone Topical Gel + adapalene gel 0.1%?
How does Dapsone Topical Gel + adapalene gel 0.1% work?
What is Dapsone Topical Gel + adapalene gel 0.1% used for?
Who makes Dapsone Topical Gel + adapalene gel 0.1%?
What drug class is Dapsone Topical Gel + adapalene gel 0.1% in?
What development phase is Dapsone Topical Gel + adapalene gel 0.1% in?
What are the side effects of Dapsone Topical Gel + adapalene gel 0.1%?
What does Dapsone Topical Gel + adapalene gel 0.1% target?
Related
- Drug class: All Combination topical antimicrobial and retinoid drugs
- Target: All drugs targeting Retinoic acid receptor (adapalene); dihydropteroate synthase inhibition (dapsone)
- Manufacturer: Allergan — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Acne vulgaris
- Compare: Dapsone Topical Gel + adapalene gel 0.1% vs similar drugs
- Pricing: Dapsone Topical Gel + adapalene gel 0.1% cost, discount & access